What is William Blair's Forecast for SERA Q1 Earnings?

Sera Prognostics, Inc. (NASDAQ:SERA - Free Report) - Analysts at William Blair issued their Q1 2026 earnings estimates for Sera Prognostics in a research note issued on Thursday, May 8th. William Blair analyst A. Brackmann forecasts that the company will post earnings of ($0.23) per share for the quarter. The consensus estimate for Sera Prognostics' current full-year earnings is ($0.96) per share. William Blair also issued estimates for Sera Prognostics' Q2 2026 earnings at ($0.23) EPS, Q3 2026 earnings at ($0.23) EPS, Q4 2026 earnings at ($0.23) EPS and FY2026 earnings at ($0.92) EPS.

Sera Prognostics Price Performance

Shares of Sera Prognostics stock opened at $2.22 on Monday. Sera Prognostics has a 1 year low of $2.10 and a 1 year high of $9.91. The firm has a market cap of $83.61 million, a PE ratio of -2.24 and a beta of 0.99. The company has a 50 day simple moving average of $3.48 and a two-hundred day simple moving average of $5.49.

Sera Prognostics (NASDAQ:SERA - Get Free Report) last announced its earnings results on Wednesday, May 14th. The company reported ($0.20) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.24) by $0.04. The company had revenue of $0.04 million for the quarter, compared to the consensus estimate of $0.06 million.

Institutional Investors Weigh In On Sera Prognostics

Several hedge funds have recently bought and sold shares of the stock. XTX Topco Ltd bought a new stake in Sera Prognostics during the first quarter valued at approximately $39,000. Perkins Capital Management Inc. bought a new stake in shares of Sera Prognostics in the 1st quarter worth approximately $522,000. Bank of New York Mellon Corp lifted its holdings in shares of Sera Prognostics by 3.6% in the 1st quarter. Bank of New York Mellon Corp now owns 135,582 shares of the company's stock worth $499,000 after acquiring an additional 4,670 shares during the last quarter. Sanders Morris Harris LLC lifted its holdings in shares of Sera Prognostics by 4.0% in the 1st quarter. Sanders Morris Harris LLC now owns 94,200 shares of the company's stock worth $347,000 after acquiring an additional 3,600 shares during the last quarter. Finally, Rhumbline Advisers lifted its holdings in shares of Sera Prognostics by 10.7% in the 1st quarter. Rhumbline Advisers now owns 39,970 shares of the company's stock worth $147,000 after acquiring an additional 3,869 shares during the last quarter. 54.64% of the stock is currently owned by institutional investors.

Sera Prognostics Company Profile

Sera Prognostics, Inc, a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.